Beximco Pharmaceuticals (BXP) News Today GBX 35 -1.50 (-4.11%) (As of 12/20/2024 10:57 AM ET) Add Compare Share Share Headlines Stock AnalysisChartCompetitorsHeadlines All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Beximco Pharmaceuticals (LON:BXP) Stock Price Up 1.4% - Time to Buy?Beximco Pharmaceuticals (LON:BXP) Trading Up 1.4% - Here's WhyDecember 6, 2024 | marketbeat.comBeximco Pharmaceuticals (LON:BXP) Share Price Crosses Above 50 Day Moving Average - What's Next?Beximco Pharmaceuticals (LON:BXP) Stock Price Passes Above 50-Day Moving Average - Here's WhyNovember 13, 2024 | marketbeat.comBeximco Pharma Share Chat (BXP)November 4, 2024 | lse.co.ukBeximco Pharmaceuticals (LON:BXP) Share Price Passes Below 200 Day Moving Average - Here's What HappenedBeximco Pharmaceuticals (LON:BXP) Stock Price Passes Below 200 Day Moving Average - Here's WhyOctober 26, 2024 | marketbeat.comForeign Investors Express Interest in Buying Beximco SubsidiariesOctober 22, 2024 | msn.comBeximco Pharmaceuticals (LON:BXP) Stock Price Up 16.4% - Still a Buy?Beximco Pharmaceuticals (LON:BXP) Stock Price Up 16.4% - Time to Buy?October 18, 2024 | marketbeat.comBXP (NYSE:BXP) Stock Quotes, Forecast and News SummaryOctober 11, 2024 | benzinga.comBeximco Pharmaceuticals (LON:BXP) Stock Price Down 24.2%Beximco Pharmaceuticals (LON:BXP) Shares Down 24.2%September 3, 2024 | marketbeat.comBeximco Pharmaceuticals (LON:BXP) Hits New 1-Year Low at $26.00Beximco Pharmaceuticals (LON:BXP) Hits New 12-Month Low at $26.00September 2, 2024 | marketbeat.comBeximco Pharmaceuticals (LON:BXP) Share Price Crosses Below 200-Day Moving Average of $38.05Beximco Pharmaceuticals (LON:BXP) Share Price Passes Below 200 Day Moving Average of $38.05August 30, 2024 | marketbeat.comMid-Year 2024 Review +10.5% / 9.3%; A Few New Ideas...July 31, 2024 | seekingalpha.comBXP, Inc.: A Well-Covered 6% Yield From A Premier Office REITJuly 19, 2024 | seekingalpha.comBeximco Pharma Share ChatFebruary 15, 2024 | lse.co.ukBeximco Pharmaceuticals Ltd DRDecember 14, 2023 | morningstar.comBeximco Pharmaceuticals Ltd. (BXPq)November 4, 2023 | investing.comBXP.L - Beximco Pharmaceuticals LimitedJune 9, 2023 | finance.yahoo.comBeximco to produce medicines in Saudi Arabia from next yearMarch 12, 2023 | msn.comBeximco PharmaceuticalsFebruary 11, 2023 | fool.co.ukBeximco Pharmaceuticals Ltd.October 26, 2022 | wsj.comBeximco Pharmaceuticals Ltd (BXPH)September 8, 2022 | investing.comBeximco Pharma Granted Sub-license To Produce Molupiravir - Quick FactsJanuary 20, 2022 | nasdaq.comBeximco Pharma Launches Generic Molnupiravir In Bangladesh To Treat Symptomatic COVID-19November 9, 2021 | nasdaq.comBeximco Pharmaceuticals Ltd. GDRAugust 2, 2021 | barrons.com Get Beximco Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for BXP and its competitors with MarketBeat's FREE daily newsletter. Email Address AI breakthrough about to upend industry (Ad)Everyone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the market in late 2022. You might think it’s way too late to invest in AI. But here’s the thing. I urge you to watch it now. BXP Media Mentions By Week BXP Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BXP News Sentiment▼0.000.60▲Average Medical News Sentiment BXP News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BXP Articles This Week▼00▲BXP Articles Average Week Get Beximco Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for BXP and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Molten Ventures News Today Prs Reit News Today DX (Group) News Today Pinewood Technologies Group News Today Triple Point Social Housing REIT News Today Saga News Today Aurora Investment Trust News Today Celtic News Today Corero Network Security News Today TClarke News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:BXP) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Beximco Pharmaceuticals Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Beximco Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
